RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: osteoporosis
Accession: DOID:11476
browse the term
Definition: A bone resorption disease characterized by decreased density of normally mineralized bone which results_in the thinning of bone tissue and decreased mechanical strength. (DO)
Synonyms: exact_synonym: Osteoporoses; age related osteoporosis; age-related bone loss; age-related bone losses; age-related osteoporoses; involutional osteoporosis; post-traumatic osteoporoses; post-traumatic osteoporosis; senile osteoporoses; senile osteoporosis
related_synonym: BMND; BMND1; BMND13; BMND16; BMND2; Bone Mineral Density Quantitative Trait Locus; Bone Mineral Density Quantitative Trait Locus 1; Bone Mineral Density Quantitative Trait Locus 12; Bone Mineral Density Quantitative Trait Locus 13; Bone Mineral Density Quantitative Trait Locus 15; Bone Mineral Density Quantitative Trait Locus 16; Bone Mineral Density Quantitative Trait Locus 17; Bone Mineral Density Quantitative Trait Locus 18; Bone Mineral Density Quantitative Trait Locus 2; FRACTURE, HIP, SUSCEPTIBILITY TO; HBM; HIGH BONE MASS; OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO; OSTEOPOROSIS, SUSCEPTIBILITY TO
primary_id: MESH:D010024
alt_id: OMIM:166710 ; OMIM:300910 ; OMIM:601884 ; OMIM:605833 ; OMIM:612560 ; OMIM:612727 ; OMIM:613418 ; OMIM:615221 ; OMIM:615311
xref: ICD10CM:M81.0 ; ICD9CM:733.0 ; NCI:C3298
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
RGD
PMID:10700189
RGD:10047094
NCBI chr 9:53,118,462...53,262,092
Ensembl chr 9:53,119,641...53,261,307
G
ACE
angiotensin I converting enzyme
ISO
associated with Hypertension
RGD
PMID:19590507
RGD:2325225
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACTG1
actin gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 9:635,978...638,328
Ensembl chr 9:635,978...638,328
G
ADCY5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18029912
NCBI chr33:26,345,617...26,490,120
Ensembl chr33:26,345,617...26,504,616
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA:increased expression:proximal end of left femur (rat)
RGD
PMID:21542009 PMID:22036861
RGD:6767561 RGD:7245948
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
ANTXR2
ANTXR cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12973667
NCBI chr32:4,143,407...4,302,194
Ensembl chr32:4,148,310...4,302,071
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr30:25,176,845...25,210,244
Ensembl chr30:25,115,842...25,218,281
G
AR
androgen receptor
treatment
ISO
RGD
PMID:14600402 PMID:18847323
RGD:10043196 RGD:10043198
NCBI chr24:34,713,390...34,731,461 NCBI chr X:51,969,785...52,167,450
Ensembl chr X:51,969,785...52,151,912
G
ATIC
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr37:22,420,645...22,446,769
Ensembl chr37:22,420,603...22,446,697
G
ATM
ATM serine/threonine kinase
ISO
RGD
PMID:16644862
RGD:10047420
NCBI chr 5:24,180,129...24,297,207
Ensembl chr 5:24,182,135...24,297,207
G
ATP4B
ATPase H+/K+ transporting subunit beta
treatment
ISO
RGD
PMID:26869358
RGD:14696735
NCBI chr22:60,898,801...60,904,223
Ensembl chr22:60,898,833...60,904,223
G
B9D2
B9 domain containing 2
treatment
ISO
associated with Uremia;protein:increased expression:osteoblast, osteoclast CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12706579 PMID:17647196
RGD:10003128
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
BGLAP
bone gamma-carboxyglutamate protein
susceptibility
ISO
DNA:SNP, haplotype:promoter:g.-298C>T (human) associated with Diabetes Mellitus, type 2;associated with Diabetes Mellitus, type 2; protein:uncercarboxylated:serum
RGD
PMID:15108065 PMID:21550389 PMID:23137636
RGD:10045665 RGD:6483552 RGD:6483579
NCBI chr 7:41,630,092...41,630,976
Ensembl chr 7:41,630,098...41,665,791
G
BMP2
bone morphogenetic protein 2
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr24:15,199,667...15,211,509
Ensembl chr24:15,200,291...15,212,217
G
CA2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr29:31,959,225...31,975,309
Ensembl chr29:31,935,172...31,980,579
G
CALCR
calcitonin receptor
susceptibility
ISO
DNA:SNP:cds:g.1340T>C (human)
OMIM RGD
PMID:23137636
RGD:10045665
NCBI chr14:18,923,116...19,074,904
Ensembl chr14:18,923,116...19,074,904
G
CAP1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:2,886,661...2,913,975
G
CCT2
chaperonin containing TCP1 subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr10:11,560,287...11,586,559
Ensembl chr10:11,560,396...11,578,433
G
CLEC11A
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27976999
NCBI chr 1:106,078,055...106,080,473
Ensembl chr 1:106,078,291...106,080,517
G
COL1A1
collagen type I alpha 1 chain
susceptibility
ISO
DNA:SNP, haplotype:intron:g.2046G>T (human)
OMIM RGD
PMID:23137636
RGD:10045665
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
COL1A2
collagen type I alpha 2 chain
ISO
OMIM
NCBI chr14:19,883,731...19,919,527
Ensembl chr14:19,883,868...19,919,527
G
CRSP-3
calcitonin receptor-stimulating peptide 3
ISO
RGD
PMID:2502220
RGD:734677
NCBI chr21:37,676,841...37,680,643
Ensembl chr21:37,676,841...37,680,645
G
CTSK
cathepsin K
ISO
RGD
PMID:10469835
RGD:734856
NCBI chr17:59,928,725...59,938,293
Ensembl chr17:59,929,287...59,938,507
G
CXCR4
C-X-C motif chemokine receptor 4
ISO
RGD
PMID:29882473
RGD:14700776
NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
ISO
DNA:snps:multiple (human)
RGD
PMID:17002564
RGD:1625350
NCBI chr28:15,292,959...15,298,896
Ensembl chr28:15,293,106...15,298,852
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism DNA:snps:multiple (human)
CTD RGD
PMID:17002564 PMID:20723554
RGD:1625350
NCBI chr30:16,954,020...17,056,728
Ensembl chr30:16,957,215...16,988,353
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22337913
NCBI chr24:39,861,018...39,878,161
Ensembl chr24:39,862,355...39,878,216
G
DAAM2
dishevelled associated activator of morphogenesis 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30598549
NCBI chr12:8,686,653...8,801,903
Ensembl chr12:8,748,655...8,799,059
G
DBP
D-box binding PAR bZIP transcription factor
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 1:107,675,138...107,681,246
Ensembl chr 1:107,675,477...107,681,204
G
DSPP
dentin sialophosphoprotein
ISO
protein:decreased expression:incisor dental pulp (rat)
RGD
PMID:23974864
RGD:12911019
NCBI chr32:11,017,440...11,022,780
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:62,300,805...62,314,508
Ensembl chr 5:62,300,808...62,304,093
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
RGD
PMID:23281008
RGD:10045609
NCBI chr 1:110,130,353...110,146,660
Ensembl chr 1:110,130,481...110,146,602
G
ESR1
estrogen receptor 1
no_association treatment
ISO
DNA:SNP, haplotype:intron:g.938C>T (human) DNA:repeat:5' utr:g.-1174(TA)10-27 (human) DNA:repeat:intron:IVS5+225(CA)18-25 (human) DNA:SNP:exon:2014G>A (human) DNA:SNP:intron:397T>C (human) DNA:SNPs:intron: (rs2234693, rs9340799) (human)
RGD
PMID:10773580 PMID:16530497 PMID:16955786 PMID:17896124 PMID:17953702 PMID:20116372 PMID:21421090 PMID:23137636
RGD:10045665 RGD:10045825 RGD:10045826 RGD:10045828 RGD:10045834 RGD:10045839 RGD:10045841 RGD:8694129
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
ESR2
estrogen receptor 2
susceptibility treatment
ISO
DNA:repeat:3' utr: g.dupCA (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:SNP, haplotypes: :-1213T>C (human)
RGD
PMID:16530497 PMID:16777502 PMID:16955786 PMID:21421090 PMID:22948905
RGD:10045825 RGD:10045841 RGD:1626507 RGD:7364765 RGD:8694129
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
ESRRA
estrogen related receptor alpha
ISO
RGD
PMID:19936213
RGD:10401868
NCBI chr18:52,755,547...52,762,938
Ensembl chr18:52,756,344...52,763,355
G
FGA
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:52,238,305...52,247,017
Ensembl chr15:52,236,198...52,246,975
G
FGB
fibrinogen beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:52,220,690...52,228,526
Ensembl chr15:52,220,611...52,228,250
G
G6PD
glucose-6-phosphate dehydrogenase
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:5448 PMID:1303173 PMID:1631957 PMID:1978554 PMID:2321910 PMID:2503817 PMID:2572288 PMID:2836867 PMID:3393536 PMID:3446582 PMID:4359638 PMID:4388132 PMID:6015571 PMID:7949118 PMID:8611726 PMID:8860013 PMID:9858856 PMID:10734064 PMID:12367584 PMID:12737938 PMID:14278484 PMID:16356170 PMID:25741868 PMID:26633385 PMID:27287612 PMID:28492532
NCBI chr X:122,217,317...122,231,862
Ensembl chr X:122,205,683...122,231,678
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr27:38,468,889...38,472,653
Ensembl chr27:38,468,889...38,472,385
G
GHR
growth hormone receptor
treatment
ISO
associated with Cholestasis associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast
RGD
PMID:17647196 PMID:19424739
RGD:10003128 RGD:10003131
NCBI chr 4:67,021,821...67,245,499
Ensembl chr 4:67,022,252...67,290,473
G
GORAB
golgin, RAB6 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18997784
NCBI chr 7:28,220,679...28,241,035
Ensembl chr 7:28,221,064...28,241,012
G
GPC6
glypican 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869591
NCBI chr22:44,154,690...45,237,398
Ensembl chr22:44,154,944...45,233,549
G
GPD2
glycerol-3-phosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr36:2,678,749...2,780,173
Ensembl chr36:2,681,188...2,777,535
G
GPX1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GSN
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr11:74,248,227...74,268,129
Ensembl chr11:74,233,457...74,268,129
G
GSR
glutathione-disulfide reductase
ISO
protein:decreased expression:blood
RGD
PMID:19464221
RGD:10401828
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
GSTP1
glutathione S-transferase pi 1
ISO
associated with Cystic Fibrosis;DNA:missense mutation:cds:c.313A>G (p.I105V) (human)
RGD
PMID:24593045
RGD:10401929
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
G
HFE
homeostatic iron regulator
ISO
associated with hemochromatosis
RGD
PMID:26829642
RGD:14746963
NCBI chr35:24,031,479...24,038,922
Ensembl chr35:24,031,387...24,042,413
G
HTR2C
5-hydroxytryptamine receptor 2C
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:87,342,800...87,641,224
Ensembl chr X:87,342,792...87,638,579
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
G
IGF1
insulin like growth factor 1
treatment
ISO
associated with Diabetes Mellitus, Experimental associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Cholestasis
RGD
PMID:1466160 PMID:10499542 PMID:17647196 PMID:19424739
RGD:10003127 RGD:10003128 RGD:10003131 RGD:10003132
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF1R
insulin like growth factor 1 receptor
ISO
RGD
PMID:18079194
RGD:10045888
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
IGF2
insulin like growth factor 2
treatment
ISO
RGD
PMID:12162999
RGD:10402555
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
IGFBP3
insulin like growth factor binding protein 3
ISO
protein:decreased expression:serum
RGD
PMID:9284698
RGD:10402579
NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:87,747,373...87,776,797
Ensembl chr X:87,747,373...87,776,798
G
IL1A
interleukin 1 alpha
ISO
associated with Arthritis, Rheumatoid
RGD
PMID:10555884
RGD:6907107
NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
G
IL1B
interleukin 1 beta
ISO
RGD
PMID:22997530
RGD:7204491
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8182127
RGD:8551834
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IL6R
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chr 7:42,877,731...42,920,149
Ensembl chr 7:42,880,885...42,920,090
G
IRS1
insulin receptor substrate 1
ISO
mRNA, protein:decreased expression:multiple
RGD
PMID:22820932
RGD:7207063
NCBI chr25:39,624,554...39,687,991
G
IRS2
insulin receptor substrate 2
ISO
associated with Diabetes Mellitus, Type 2; protein:decreased expression:liver,kidney, muscle:
RGD
PMID:22820932
RGD:7207063
NCBI chr22:58,197,016...58,229,026
Ensembl chr22:58,223,387...58,227,535
G
KL
klotho
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9363890
RGD:10403047
NCBI chr25:7,154,359...7,201,744
Ensembl chr25:7,156,620...7,199,558
G
LEP
leptin
treatment
ISO
associated with chronic obstructive pulmonary disease; protein:decreased expression:serum human protein in a rat model protein:increased expression:serum (rat)
RGD
PMID:11459801 PMID:12609558 PMID:21376149 PMID:24250662
RGD:10053572 RGD:10053615 RGD:10053630 RGD:5128771
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
LEPR
leptin receptor
susceptibility
ISO
DNA:polymorphisms:cds:p.K109R,Q223R(human)
RGD
PMID:23460508
RGD:10411886
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
LGR4
leucine rich repeat containing G protein-coupled receptor 4
susceptibility
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 17 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:23644456
NCBI chr21:47,952,019...47,995,530
Ensembl chr21:47,952,890...47,996,288
G
LOC106557476
tubulin alpha-1A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr27:5,407,906...5,412,265
Ensembl chr27:5,407,906...5,463,809
G
LOC480777
UDP-glucuronosyltransferase 2A1
ISO
OMIM
NCBI chr13:58,911,301...58,932,594
Ensembl chr13:59,138,348...59,222,802
G
LRCH2
leucine rich repeats and calponin homology domain containing 2
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:87,865,007...87,968,658
Ensembl chr X:87,866,969...87,968,883
G
LRP5
LDL receptor related protein 5
treatment
ISO
OMIM RGD
PMID:21977807 PMID:22704852
RGD:12793063 RGD:7240519
NCBI chr18:49,439,494...49,555,375
Ensembl chr18:49,439,483...49,516,396
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16648989 PMID:16936800
NCBI chr20:42,231,994...42,263,202
Ensembl chr20:42,231,994...42,263,202
G
LUZP4
leucine zipper protein 4
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:88,041,381...88,063,726
Ensembl chr X:88,041,376...88,063,708
G
MAPK14
mitogen-activated protein kinase 14
treatment
ISO
RGD
PMID:18442314
RGD:10045965
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
G
MGLL
monoglyceride lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr20:1,765,650...1,880,710
Ensembl chr20:1,766,216...1,943,588
G
MIR152
microRNA mir-152
ISO
miRNA:increased expression:femur
RGD
PMID:31492082
RGD:21066345
NCBI chr 9:24,335,161...24,335,219
Ensembl chr 9:24,335,146...24,335,225
G
MIR448
microRNA mir-448
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:87,558,063...87,558,172
Ensembl chr X:87,558,063...87,558,172
G
MMP9
matrix metallopeptidase 9
ISO
associated with osteoporosis; protein:increased expression:serum
RGD
PMID:19411568
RGD:5129553
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
RGD
PMID:22704852
RGD:7240519
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
G
NOG
noggin
ISO
RGD
PMID:12975477
RGD:10414323
NCBI chr 9:31,453,604...31,456,060
G
NRIP1
nuclear receptor interacting protein 1
ISO
DNA:silent mutation, haplotype:p.G75G (human)
RGD
PMID:16530497
RGD:10045825
NCBI chr31:11,852,330...11,951,735
Ensembl chr31:11,855,338...11,932,056
G
OPA1
OPA1 mitochondrial dynamin like GTPase
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868
NCBI chr23:52,068,123...52,154,410
Ensembl chr23:52,068,118...52,151,593
G
OXCT1
3-oxoacid CoA-transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:67,709,846...67,841,737
Ensembl chr 4:67,527,531...67,841,518
G
P4HB
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 9:427,827...436,880
Ensembl chr 9:427,830...436,064
G
PARK7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:61,576,219...61,592,325
Ensembl chr 5:61,576,069...61,592,303
G
PCNA
proliferating cell nuclear antigen
ISO
protein:increased expression:osteoblast:
RGD
PMID:22550338
RGD:10045656
NCBI chr24:16,478,774...16,485,992
Ensembl chr24:16,478,769...16,484,992
G
PDLIM4
PDZ and LIM domain 4
ISO
OMIM
NCBI chr11:20,570,839...20,587,185
Ensembl chr11:20,570,833...20,585,594
G
PGLS
6-phosphogluconolactonase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr20:45,293,970...45,301,074
Ensembl chr20:45,294,008...45,301,038
G
PKM
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr30:35,712,853...35,737,643
G
PLEK
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr10:67,395,972...67,421,247
Ensembl chr10:67,395,972...67,421,247
G
PLS3
plastin 3
ISO
OMIM
NCBI chr X:88,308,817...88,399,682
Ensembl chr X:88,308,888...88,398,810
G
PNP
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:17,808,454...17,815,987
Ensembl chr15:17,808,461...17,815,676
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3017235 PMID:4367732 PMID:6143199 PMID:6254450 PMID:19153526
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
PRDX3
peroxiredoxin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr28:29,395,593...29,403,745
Ensembl chr28:29,395,581...29,403,745
G
PSMA2
proteasome 20S subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr18:7,218,150...7,228,859
Ensembl chr18:7,218,080...7,228,816
G
PSMA5
proteasome 20S subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:42,425,590...42,450,074
Ensembl chr 6:42,425,624...42,449,925
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:16442794
RGD:10043381
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
PTH
parathyroid hormone
treatment
ISO
protein:decreased expression:serum (rat) CTD Direct Evidence: therapeutic
RGD CTD
PMID:15710971 PMID:17317460 PMID:17882678 PMID:19578808 PMID:21306167 PMID:22312238 PMID:23161222 PMID:30639440
RGD:7242793 RGD:7242907
NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
G
RAB7B
RAB7B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr38:2,333,939...2,359,531
Ensembl chr38:2,335,535...2,359,469
G
REN
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18847324
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
RSU1
Ras suppressor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 2:20,050,029...20,299,179
Ensembl chr 2:20,050,117...20,299,184
G
RYR1
ryanodine receptor 1
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:114,461,350...114,579,577
Ensembl chr 1:114,461,348...114,579,493
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:22555620 PMID:25377437
RGD:10047129 RGD:10053568
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
SOD2
superoxide dismutase 2
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:intron, exon:g.31A>G, g.327C>T (p.A16V) (rs5746094, rs4880) (human) DNA:SNPs:5' utr, exon, intron:multiple
CTD RGD
PMID:18924182 PMID:26336112
RGD:11035299
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
TLN1
talin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr11:52,227,286...52,260,112
Ensembl chr11:52,227,611...52,259,915
G
TNFRSF11A
TNF receptor superfamily member 11a
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 1:14,504,595...14,555,956
Ensembl chr 1:14,503,033...14,556,041
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17667143
NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 2:84,140,179...84,151,219
Ensembl chr 2:84,141,911...84,157,191
G
TNFSF11
TNF superfamily member 11
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:17002564 PMID:17882678
RGD:1625350
NCBI chr22:8,226,931...8,257,926
Ensembl chr22:8,227,555...8,258,645
G
TPI1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr27:38,154,519...38,157,900
Ensembl chr27:38,154,519...38,158,137
G
TPM4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr20:46,354,808...46,376,489
Ensembl chr20:46,355,736...46,376,425
G
TUBA1C
tubulin alpha 1c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr27:5,333,706...5,340,363
G
U2AF1
U2 small nuclear RNA auxiliary factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr31:37,263,265...37,276,710
G
VCL
vinculin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:24,404,279...24,518,977
Ensembl chr 4:24,404,319...24,518,633
G
VDR
vitamin D receptor
no_association
ISO
associated with Cystic Fibrosis
RGD
PMID:16713399
RGD:4889871
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
WDR1
WD repeat domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:69,305,731...69,348,183
Ensembl chr 3:69,305,731...69,348,177
G
WNT1
Wnt family member 1
susceptibility
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 16 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:23499309 PMID:23656646
NCBI chr27:5,588,151...5,592,254
Ensembl chr27:5,574,940...5,592,060
G
ZDHHC13
zinc finger DHHC-type palmitoyltransferase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20548961
NCBI chr21:41,243,214...41,292,458
Ensembl chr21:41,243,294...41,291,995
G
F12
coagulation factor XII
ISO
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532
NCBI chr 4:35,950,642...35,968,137
Ensembl chr 4:35,950,695...35,998,025
G
SLC34A1
solute carrier family 34 member 1
ISO
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532
NCBI chr 4:35,961,394...35,973,733
Ensembl chr 4:35,961,958...35,973,657
G
F12
coagulation factor XII
ISO
ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic, 1
ClinVar
PMID:28492532
NCBI chr 4:35,950,642...35,968,137
Ensembl chr 4:35,950,695...35,998,025
G
SLC34A1
solute carrier family 34 member 1
ISO
OMIM
NCBI chr 4:35,961,394...35,973,733
Ensembl chr 4:35,961,958...35,973,657
G
SLC9A3R1
SLC9A3 regulator 1
ISO
OMIM
NCBI chr 9:5,661,792...5,679,783
Ensembl chr 9:5,662,464...5,679,570
G
LRP5
LDL receptor related protein 5
ISO
DNA:mutations:exon:c.3446 T > A (p.L1149Q),c.3553 G > A (p.G1185R)(human)
RGD
PMID:22487062
RGD:12793058
NCBI chr18:49,439,494...49,555,375
Ensembl chr18:49,439,483...49,516,396
G
ACP5
acid phosphatase 5, tartrate resistant
ISO
protein:increased expression:femur (rat)
RGD
PMID:19736603
RGD:2315910
NCBI chr20:49,812,444...49,816,262
Ensembl chr20:49,814,032...49,816,260
G
AR
androgen receptor
ISO
RGD
PMID:12593895
RGD:1578682
NCBI chr24:34,713,390...34,731,461 NCBI chr X:51,969,785...52,167,450
Ensembl chr X:51,969,785...52,151,912
G
B9D2
B9 domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10750555
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BMP15
bone morphogenetic protein 15
susceptibility
ISO
DNA:SNPs, haplotype:5' utr, intron:g.-9C>G, IVS1+905A>G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chr X:43,765,126...43,771,277
Ensembl chr X:43,764,777...43,771,287
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17227729
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
COL1A1
collagen type I alpha 1 chain
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:2037280 PMID:7695699 PMID:7942841 PMID:8218237 PMID:8408653 PMID:8613526 PMID:8669434 PMID:8808594 PMID:9016532 PMID:9067755 PMID:9295084 PMID:9443882 PMID:10931857 PMID:12590186 PMID:15024692 PMID:15024745 PMID:15741671 PMID:15864348 PMID:15931785 PMID:17078022 PMID:17309652 PMID:18412368 PMID:18553566 PMID:18704262 PMID:19344236 PMID:19358256 PMID:21249479 PMID:21567126 PMID:21667357 PMID:22589248 PMID:22753364 PMID:24390061 PMID:25086671 PMID:25741868 PMID:25944380 PMID:25963598 PMID:26177859 PMID:26467025 PMID:27132807 PMID:27509835 PMID:27510842 PMID:27748872 PMID:28378289 PMID:28492532
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
COL1A2
collagen type I alpha 2 chain
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:1463018 PMID:1978725 PMID:2052622 PMID:2985635 PMID:7695699 PMID:7860070 PMID:8094076 PMID:8218237 PMID:8786074 PMID:9016532 PMID:9272740 PMID:9399846 PMID:9594376 PMID:9923651 PMID:15172002 PMID:16705691 PMID:17078022 PMID:18028452 PMID:19344236 PMID:21520333 PMID:22589248 PMID:25326637 PMID:25450603 PMID:25741868 PMID:25944380 PMID:26432670 PMID:26604951 PMID:27519266 PMID:28492532
NCBI chr14:19,883,731...19,919,527
Ensembl chr14:19,883,868...19,919,527
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
ISO
DNA:snps:exon:multiple (human)
RGD
PMID:17118999
RGD:1600860
NCBI chr30:16,954,020...17,056,728
Ensembl chr30:16,957,215...16,988,353
G
ESR1
estrogen receptor 1
treatment susceptibility
ISO
DNA:SNP:intron:IVS1T>C (human) DNA:SNPs, haplotype:intron: (rs2234693, rs9340799) (human)
RGD
PMID:16604479 PMID:16972020
RGD:10045838 RGD:8158082
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
ESR2
estrogen receptor 2
susceptibility
ISO
DNA:SNP: :-1213T>C (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:repeat:intron:IVS5-3919(CA)18-26 (human)
RGD
PMID:16777502 PMID:17945165 PMID:22335445
RGD:10045847 RGD:10045849 RGD:1626507
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
FDPS
farnesyl diphosphate synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31774873
NCBI chr 7:42,241,086...42,250,373
Ensembl chr 7:42,241,107...42,250,225
G
FGF23
fibroblast growth factor 23
ISO
protein:increased expression: :
RGD
PMID:24101107
RGD:10044241
NCBI chr27:40,501,655...40,511,785
Ensembl chr27:40,501,731...40,509,766
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:18067744 PMID:24023068
RGD:10402191 RGD:10402540
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:11063288
RGD:10045861
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF2
insulin like growth factor 2
treatment
ISO
RGD
PMID:16753016
RGD:10402556
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IL7
interleukin 7
treatment
ISO
RGD
PMID:23662133
RGD:10402930
NCBI chr29:26,384,493...26,422,586
Ensembl chr29:26,384,493...26,422,737
G
LRP5
LDL receptor related protein 5
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr18:49,439,494...49,555,375
Ensembl chr18:49,439,483...49,516,396
G
NRIP1
nuclear receptor interacting protein 1
susceptibility
ISO
DNA:silent mutation:cds:p.G75G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chr31:11,852,330...11,951,735
Ensembl chr31:11,855,338...11,932,056
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:11917107
RGD:10003045
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
PTH
parathyroid hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20567999
NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
G
PTK2B
protein tyrosine kinase 2 beta
ISO
RGD
PMID:17537919
RGD:1642610
NCBI chr25:30,137,546...30,264,221
Ensembl chr25:30,138,209...30,264,133
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
VDR
vitamin D receptor
treatment
ISO
DNA:SNP:exon: (rs2228570) (human) ClinVar Annotator: match by term: Postmenopausal osteoporosis
RGD ClinVar
PMID:16604479 PMID:25741868
RGD:8158082
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
IFIH1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr36:7,668,925...7,727,040
Ensembl chr36:7,649,727...8,261,048
G
IFIH1
interferon induced with helicase C domain 1
ISO
OMIM
NCBI chr36:7,668,925...7,727,040
Ensembl chr36:7,649,727...8,261,048
G
DDX58
DExD/H-box helicase 58
ISO
OMIM
NCBI chr11:49,764,252...49,799,626
Ensembl chr11:49,764,267...49,799,527
G
MMP14
matrix metallopeptidase 14
ISO
OMIM
NCBI chr 8:3,183,419...3,193,079
Ensembl chr 8:3,183,606...3,194,122
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
disease
13588
Diseases of the Aged
1039
osteoporosis
134
Amino Aciduria with Mental Deficiency, Dwarfism, Muscular Dystrophy, Osteoporosis, and Acidosis
0
Diabetic Bone Disease
0
Female Athlete Triad Syndrome
0
Growth Failure, Microcephaly, Mental Retardation, Cataracts, Large Joint Contractures, Osteoporosis, Cortical Dysplasia, and Cerebellar Atrophy
0
Hernandez Fragoso Syndrome
0
Infantile Multisystem Neurologic Disease with Osseous Fragility
0
Macroepiphyseal Dysplasia, McAlister Coe Type
0
Postmenopausal Osteoporosis
25
Prader-Willi Habitus, Osteopenia, and Camptodactyly
0
Premature Aging, Okamoto Type
0
Singleton Merten Syndrome +
2
Winchester syndrome
1
glucocorticoid-induced osteoporosis
0
hypophosphatemic nephrolithiasis/osteoporosis +
3
idiopathic juvenile osteoporosis
1
Path 2
disease
13588
disease of anatomical entity
13248
Skin and Connective Tissue Diseases
4967
connective tissue disease
3848
bone disease
2591
bone remodeling disease
227
bone resorption disease
158
osteoporosis
134
Amino Aciduria with Mental Deficiency, Dwarfism, Muscular Dystrophy, Osteoporosis, and Acidosis
0
Diabetic Bone Disease
0
Female Athlete Triad Syndrome
0
Growth Failure, Microcephaly, Mental Retardation, Cataracts, Large Joint Contractures, Osteoporosis, Cortical Dysplasia, and Cerebellar Atrophy
0
Hernandez Fragoso Syndrome
0
Infantile Multisystem Neurologic Disease with Osseous Fragility
0
Macroepiphyseal Dysplasia, McAlister Coe Type
0
Postmenopausal Osteoporosis
25
Prader-Willi Habitus, Osteopenia, and Camptodactyly
0
Premature Aging, Okamoto Type
0
Singleton Merten Syndrome +
2
Winchester syndrome
1
glucocorticoid-induced osteoporosis
0
hypophosphatemic nephrolithiasis/osteoporosis +
3
idiopathic juvenile osteoporosis
1